Skip to content

Drug interactions

Bosutinib + Tetracycline

Severity: Minor

Bosutinib and Tetracycline: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tetracycline is not an established clinically relevant CYP3A4 inhibitor, so a substantial increase in bosutinib exposure is unlikely. The concern is theoretical and extrapolated from the class of CYP3A inhibitors.

What this interaction means in plain words

Bosutinib and Tetracycline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Bosutinib belongs to Oncology; Tetracycline belongs to Anti Bacterial.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition; not well established for tetracycline.

What to do

No empiric dose change is needed; monitor for bosutinib gastrointestinal, hepatic and hematologic toxicity as usual.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosutinib and Tetracycline, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosutinib with Tetracycline?

MediHelp rates the interaction as minor. Bosutinib and Tetracycline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tetracycline is not an established clinically relevant CYP3A4 inhibitor, so a substantial increase in bosutinib exposure is unlikely. The concern is theoretical and extrapolated from the class of CYP3A inhibitors.

How serious is the interaction between Bosutinib and Tetracycline?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empiric dose change is needed; monitor for bosutinib gastrointestinal, hepatic and hematologic toxicity as usual.

What other medicines interact with Tetracycline?

MediHelp also lists interactions of Tetracycline with, for example, Acitretin, Methoxyflurane, Isotretinoin. The full list is on the Tetracycline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in